California Senate Committee Advances Bill Clarifying Cannabis and Cannabinoid Enforcement Rules After Unanimous Assembly Vote
- California Assembly Bill 2250, aimed at revising state rules on cannabis, cannabinoids, and enforcement against unlicensed sales, has advanced out of a Senate committee following unanimous approval in the Assembly.
- The bill, sponsored by Assemblymember Cecilia Aguiar-Curry, extends the exclusion of CBD isolate from the definition of "cannabis concentrate" to include CBN isolate starting January 1, 2028, building on previous reforms under AB 8.
- AB 2250 clarifies Cannabis Tax Law provisions, allowing rebuttal of the presumption that cannabinoid-containing products are cannabis products if they comply with state industrial hemp laws, and strengthens enforcement authority to seize cannabis products at unlicensed premises.
- The bill also broadens restrictions under the Cigarette and Tobacco Products Licensing Act by prohibiting tobacco retailers from selling cannabis or related products and expanding the authority to seize such products sold in violation of the act; the bill now awaits further Senate committee and full Senate approval before reaching the governor.
A California bill that would revise several state rules related to cannabis, cannabinoids and enforcement against unlicensed sales has advanced out of a Senate committee after previously clearing the full Assembly without opposition.
Assembly Bill 2250, sponsored by Assemblymember Cecilia Aguiar-Curry, was approved June 15 by the Senate Business, Professions and Economic Development Committee in an 11 to 0 vote. The measure was then re-referred to the Senate Revenue and Taxation Committee for further consideration.
The vote follows the bill’s May 22 approval by the full Assembly, where it passed 72 to 0.
AB 2250 builds on changes enacted last year under AB 8, which revised California’s rules for industrial hemp raw extract, cannabinoids and cannabis-related enforcement. Among other provisions, AB 8 excluded CBD isolate from the definition of “cannabis concentrate” under the California Uniform Controlled Substances Act beginning in 2028. AB 2250 would extend that exclusion to CBN isolate, also beginning January 1, 2028.
The bill would also make organizational and clarifying changes to provisions of the Cannabis Tax Law that create a presumption that a product containing, or claiming to contain, a cannabinoid is a cannabis product. That presumption can be rebutted with evidence that the product complies with state industrial hemp laws or otherwise meets the definition of industrial hemp.
AB 2250 would further revise enforcement language related to unlicensed premises. Under the bill, state tax officials or law enforcement could seize cannabis or cannabis products that are possessed, stored, offered for sale or sold at an unlicensed premises.
The proposal also expands restrictions under the Cigarette and Tobacco Products Licensing Act. Current law prohibits tobacco retailers from possessing, storing, owning or making retail sales of cannabis, cannabis products or products presumed to be cannabis. AB 2250 would broaden that prohibition to cover any sale of those products, while expanding seizure authority to include cannabis or cannabis products sold in violation of the act.
With the Senate committee vote complete, AB 2250 now awaits action in the Senate Revenue and Taxation Committee. If approved there, it would still need to clear the full Senate before it could be sent to Governor Gavin Newsom.